Tashkent, Uzbekistan (UzDaily.com) -- A ceremony of signing a trilateral agreement on the implementation of the investment project "Organization of production of solid dosage forms in the form of tablets, hard gelatin capsules and dosed powders" with the Egyptian company SOLYPHAR was held in Tashkent, Dunyo news agency reported.

This joint project will be implemented in accordance with the agreements reached during the official visit of the President of the Arab Republic of Egypt Abdul-Fattah al-Sisi to Uzbekistan in September 2018.

The agreement on the implementation of the investment project was signed by the deputy khokim of Tashkent region Jamshid Abdusalomov, the director of the Agency for the Development of the Pharmaceutical Industry Sardor Kariev and the President of the SOLYPHAR company Omar Abdel El-Alem.

The signing ceremony was also attended by the Ambassador of Egypt Amira Fahmi, Deputy Minister of Health Shohrukh Sharakhmetov, representatives of ministries and departments, large local pharmaceutical companies.

The director of the Agency for the Development of the Pharmaceutical Industry Sardor Kariev said that the joint project provides for the construction of a new facility in the Tashkent region worth more than US$20 million.

- The annual production capacity will be 500 million tablets, 200 million capsules and 10 million sachets. In general, there are more than 120 types of drugs. The new production will meet the requirements of Good Manufacturing Practice - GMP.

Also, due to the launch of the facility, more than 200 new jobs will be created. Through the introduction of new and advanced technologies, it is planned to organize training of local specialists in new opportunities for the production of high-quality products.

Following the meeting, the ceremony participants expressed their hope for achieving successful results from joint activities in the near future.